Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nu 3

Next Previous
Search
Drug Profile

Nu 3

Alternative Names: Bisphosphocin Nu-3; Nu-3; Nubiotics

Latest Information Update: 05 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oligos Etc.
  • Developer Lakewood Amedex
  • Class Anti-infectives; Anti-inflammatories; Antibacterials; Antifungals; Foot disorder therapies; Skin disorder therapies; Small molecules
  • Mechanism of Action Cell membrane structure modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Diabetic foot ulcer
  • No development reported Stomatitis
  • Discontinued Burn infections; Lung disorders; Lyme disease; Onychomycosis; Urinary tract infections

Most Recent Events

  • 05 Sep 2023 Chemical structure information added
  • 28 Feb 2023 No recent reports of development identified for preclinical development in Stomatitis in USA (Topical, Gel)
  • 15 Jun 2022 Lakewood-Amedex terminates a phase-II clinical trial in Diabetic foot ulcer (Adjunctive treatment, In adults, In the elderly, Treatment-experienced) in USA due to requirement of additional preclinical data (Topical) (NCT05276401)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top